10/09/2018 - 13:14

Pharmaust anti-cancer drug gets independent nod

10/09/2018 - 13:14

Bookmark

Upgrade your subscription to use this feature.

Researchers at the Olivia Newton-John Cancer Research Institute in Melbourne have independently confirmed the ability of Pharmaust’s anti-cancer drug, Monepantel, to impact cancer cells. This includes other previously untested human melanoma cancer cell lines. The research also found that the drug became progressively more effective over a longer time whilst having minimal impact on two non-cancerous ovarian cell lines.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options